Sheffield based British Tinnitus Association appoints Head of Research

To cement their position as a leader in tinnitus research, Sheffield based charity the British Tinnitus Association (BTA) has appointed Dr Magdalena Sereda as their first Head of Research.

Dr Sereda will be based at the NIHR Nottingham Hearing Biomedical Research Unit (BRU) which is a partnership between Nottingham University Hospitals NHS Trust, the University of Nottingham and the MRC Institute of Hearing Research (MRC IHR).

Dr Sereda’s research programme will form an entirely new strand of tinnitus research within the BRU addressing issues and controversies around tinnitus management within the NHS.

The programme was designed to address research priorities identified by the James Lind Alliance Tinnitus Priority Setting Partnership. Initially, she will be researching the use of hearing aids and combination hearing aids in tinnitus management.

As the role develops, further research projects will be led by Dr Sereda addressing areas of need identified by the tinnitus community.

The BTA is the only UK charity solely dedicated to supporting the millions of people in the UK who are affected by tinnitus, a sound in the ears with no external source, known cause, or current cure.

Dr Sereda said: “The BTA Head of Research position is unique in the way that it supports research directly relevant for people with tinnitus. The Nottingham Hearing BRU strongly believes in patient and public involvement from the early research stages onwards and this is very close to my heart.

“I look forward to working in close collaboration with people with tinnitus, the BTA and clinicians to make my research relevant and important and to address current hot topics and issues around management of tinnitus within the NHS.”

David Stockdale, chief executive of the BTA, said: “We are delighted to have appointed Magdalena as our first Head of Research. The BTA has supported and commissioned research since our inception.

“This is enshrined in our mission statement and several of our strategic priorities. The BTA aims to ultimately find a cure for tinnitus but also seek to prove the efficacy or otherwise of current treatments and seek a better understanding of the impact and burden of tinnitus on the UK.

“There is little spent on tinnitus research when compared to similar conditions and it is clear from surveys of BTA members they view the BTA’s support of research as the most vital area of its work. This appointment further demonstrates the BTA’s position as a world leader in supporting tinnitus research.”

Dr Magdalena Sereda

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.